Get started
CRISPR Therapeutics AG

CRSP- Pioneer and leader in gene editing

203
CRSP is the leader and pioneer of the CRISPR/CAS9 gene-editing breakthrough. It is a long-term bet as short-term to mid-term future is uncertain.

I think it has one more leg down. Accumulate in the demand zone.
Libratus
Also on:
beamCRSPcrsprEDITFundamental AnalysisgeneeditingTechnical IndicatorsNTLATrend Analysis

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
beamCRSPcrsprEDITFundamental AnalysisgeneeditingTechnical IndicatorsNTLATrend Analysis
Libratus
Also on:

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.